Multicenter phase H trial of biweekly carboplatin and gemcitabine for untreated advanced non-small-cell lung cancer (NSCLC)

被引：0
|
作者：
Dómine, M
Gómez, RG
Firvida, JL
Delgado, JR
Estévez, LG
León, A
Casado, V
Alvarez, R
Alfonso, AL
Lobo, F
机构：
[1] Univ Autonoma Madrid, Fdn Jimenez Diaz, Serv Oncol, Madrid, Spain
[2] Hosp Gregorio Maranon, Med Oncol Serv, E-28007 Madrid, Spain
[3] Complejo Hosp Orense, Serv Oncol Med, Orense, Spain
[4] Hosp Univ Virgen Nieves, Med Oncol Serv, Granada, Spain
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：308 / 308
页数：1
相关论文
共 50 条
  • [1] Biweekly carboplatin and gemcitabine for untreated advanced non-small cell lung cancer (NSCLC). A multicenter phase II trial
    Domine, M
    Gomez, RG
    Firvida, J
    Delgado, J
    Estevez, L
    Docampo, LI
    Leon, A
    Pachon, V
    Casado, V
    Lobo, F
    [J]. LUNG CANCER, 2005, 49 : S242 - S242
  • [2] Vinorelbine/gemcitabine in advanced non-small-cell lung cancer (NSCLC): A phase I trial
    Pirker, R
    Krajnik, G
    MohnStaudner, A
    Marhold, F
    Malayeri, R
    Zochbauer, S
    Kummer, F
    Greil, R
    Huber, H
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1139 - 1139
  • [3] A new biweekly schedule of carboplatin and gemcitabine: Phase I feasibility trial in patients with advanced non-small cell lung cancer (NSCLC).
    Mancuso, A
    Migliorino, MR
    Martelli, O
    Belli, R
    Di Molfetta, M
    De Petris, L
    Di Salvia, R
    De Marinis, F
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 677S - 677S
  • [4] Phase II trial of gemcitabine, docetaxel, and cetuximab in advanced non-small-cell lung cancer (NSCLC)
    Rubinsak, J. R.
    Spigel, D. R.
    Hainsworth, J. D.
    Webb, C.
    Inhorn, R. C.
    Infante, J. R.
    Yardley, D. A.
    Burris, H. A., III
    Vazquez, E. R.
    Greco, F. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Phase II trial of gemcitabine in advanced non-small-cell lung cancer
    Malayeri, R
    Ulsperger, E
    Baumgartner, G
    Forstner, B
    Aigner, K
    Hubner, M
    Kummer, F
    Krajnik, G
    Zochbauer, S
    Krejcy, K
    Huber, H
    Pirker, R
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 1997, 109 (17) : 688 - 691
  • [6] Vinorelbine-gemcitabine in advanced non-small-cell lung cancer (NSCLC):: An AASLC phase II trial
    Krajnik, G
    Mohn-Staudner, A
    Thaler, J
    Greil, R
    Schmeikal, S
    Marhold, F
    Deutsch, J
    Preiss, P
    Malayeri, R
    Schäfer-Prokop, C
    Wein, W
    Huber, H
    Pirker, R
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (08) : 993 - 998
  • [7] Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer
    Wang, Lin Run
    Huang, Ming Zhu
    Zhang, Guo Bing
    Xu, Nong
    Wu, Xiu Hua
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 601 - 607
  • [8] Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer
    Lin Run Wang
    Ming Zhu Huang
    Guo Bing Zhang
    Nong Xu
    Xiu Hua Wu
    [J]. Cancer Chemotherapy and Pharmacology, 2007, 60 : 601 - 607
  • [9] Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer
    Javier Castro de Carpeño
    M. González Barón
    J. Aguiar
    J. I. Chacón
    J. Feliu
    M. J. García
    C. Madroñal
    A. Colmenarejo
    J. J. Sánchez
    A. Ordóñez
    [J]. Cancer Chemotherapy and Pharmacology, 2006, 58
  • [10] Biweekly regimen of cisplatin, gemcitabine and vinorelbine for advanced non-small-cell lung cancer
    de Carpeño, JC
    Barón, MG
    Aguiar, J
    Chacón, JI
    Feliu, J
    García, MJ
    Madroñal, C
    Colmenarejo, A
    Sánchez, JJ
    Ordóñez, A
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (02) : 266 - 271
12345